NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 266 filers reported holding NOVOCURE LTD in Q2 2023. The put-call ratio across all filers is 0.33 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $310,571 | -9.7% | 5,164 | +14.2% | 0.02% | -25.0% |
| Q3 2022 | $344,000 | +15.1% | 4,522 | +5.2% | 0.02% | +17.6% |
| Q2 2022 | $299,000 | -16.5% | 4,298 | -0.5% | 0.02% | 0.0% |
| Q1 2022 | $358,000 | +6.5% | 4,318 | -3.5% | 0.02% | 0.0% |
| Q4 2021 | $336,000 | -37.1% | 4,473 | -2.7% | 0.02% | -43.3% |
| Q3 2021 | $534,000 | -53.1% | 4,595 | -10.4% | 0.03% | -51.6% |
| Q2 2021 | $1,138,000 | +69.6% | 5,130 | +1.0% | 0.06% | +55.0% |
| Q1 2021 | $671,000 | -24.4% | 5,078 | -0.9% | 0.04% | -33.3% |
| Q4 2020 | $887,000 | +63.4% | 5,126 | +5.0% | 0.06% | +46.3% |
| Q3 2020 | $543,000 | +56.5% | 4,880 | -16.7% | 0.04% | +10.8% |
| Q2 2020 | $347,000 | – | 5,858 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 350,884 | $26,344,000 | 8.01% |
| HARTLINE INVESTMENT CORP/ | 318,109 | $23,884,000 | 3.27% |
| Deep Track Capital, LP | 550,000 | $41,294,000 | 2.92% |
| MORGAN JESS S & CO INC | 43,975 | $3,302,000 | 2.03% |
| Taylor Frigon Capital Management LLC | 46,376 | $3,482,000 | 1.09% |
| Darsana Capital Partners LP | 258,937 | $19,441,000 | 0.90% |
| Private Harbour Investment Management & Counsel, LLC | 13,562 | $1,018,000 | 0.81% |
| Rhenman & Partners Asset Management AB | 120,387 | $9,610,000 | 0.64% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $751,000 | 0.50% |
| Baillie Gifford | 9,615,168 | $721,906,000 | 0.40% |